Elsevier Announces New Editor-in-Chief of Trends in Cardiovascular Medicine
Philadelphia, March 19, 2014
Douglas P. Zipes, M.D.
Douglas P. Zipes, M.D.
Douglas P. Zipes, M.D., has been named the new Editor-in-Chief of Trends in Cardiovascular Medicine, Elsevier announced today. Dr. Zipes will succeed Elizabeth Nabel, M.D., who has served as Editor-in-Chief since 2004.
Douglas P. Zipes, M.D., serves as a Distinguished Professor at the Krannert Institute of Cardiology at Indiana University. He has also held other positions at Indiana University, including Professor of Medicine, Pharmacology and Toxicology in 1994 and Director of the Cardiology Division at the Krannert Institute of Cardiology.
Dr. Zipes received his B.A. cum laude from Dartmouth College, his M.D. cum laude from Harvard Medical School, and his postgraduate training at Duke University Medical Center. A past chairman of the American Board of Internal Medicine, he is the past president of several professional organizations, including the Cardiac Electrophysiology Society, the Association of University Cardiologists, the Heart Rhythm Society, and the American College of Cardiology.
Dr. Zipes is a specialist on the research and treatment of cardiac arrhythmias and led the team that developed the very first implantable cardioverter. Among many contributions, he pioneered an alcohol ablation catheterization technique that cures some arrhythmias and is a specialist in many arrhythmia areas, including sudden death.
Dr. Zipes was the founding editor of HeartRhythm; is the editor of Elsevier’s Practice Update: Cardiology; and has authored over 800 articles and 24 textbooks, including Braunwald’s Heart Disease: A Textbook of Cardiovascular Medicine, Cardiac Electrophysiology: From Cell to Bedside, Clinical Arrhythmology and Electrophysiology, and Electrocardiography of Arrhythmias. In addition, he writes a regular column for the Saturday Evening Post called “Heart Health: Ask Dr. Zipes.”
Dr. Zipes stated, “I am honored to become editor of TCM. It is my goal to make it a valuable addition to the educational choices for clinicians and basic scientists in cardiology. A unique feature will be to link PracticeUpdate/Cardiology and Braunwald’s Heart Disease in this educational effort.”
Trends in Cardiovascular Medicine provides in-depth state-of-the-art reviews of scientific advances in cardiovascular medicine, written and critiqued by internationally known experts. Articles present an authoritative understanding on a range of topics, including basic mechanisms, diagnosis, treatment, and prognosis of heart and blood vessel disorders for clinicians and basic scientists. Topics offer insights into all aspects of cardiology, ranging from arrhythmias to vasculopathies.
Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions — among them ScienceDirect, Scopus, Elsevier Research Intelligence, and ClinicalKey — and publishes nearly 2,200 journals, including The Lancet and Cell, and over 25,000 book titles, including a number of iconic reference works.
The company is part of Reed Elsevier Group PLC, a world leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).
+1 215 239 3704